- Free + $20/mo Personal + Institutional.
- Not disclosed
- Not disclosed
- —
- 2018
- US
Scite
by Scite (Research Solutions) · founded 2018 · US
Smart Citations: classifies whether papers support or contradict claims.
- Regulatory & Compliance0/11
No FDA clearance listed
- Clinical Integration0/7.8
No EHR integrations listed
- Evidence Strength27/27
5 peer-reviewed papers
- Vendor & Market14.4/18
market_relevance=75 (mid-tier funding/adoption)
- Sentiment & Transparency3.3/15.5
1 pricing tier(s) but no $ amounts (contact-sales pattern)
▸ Show all 11 dimensions▾ Hide dimension detail
- FDA clearance0/6
No FDA clearance listed
- HIPAA / SOC2 / BAA0/5
No public HIPAA/SOC2/BAA attestation
- EHR integrations (count)0/4
No EHR integrations listed
- Top-3 EHR coverage (Epic / Oracle / Athena)0/2
None of the top-3 EHRs covered
- Bidirectional write-back0/1
No bidirectional write-back documented
- Peer-reviewed papers21/21
5 peer-reviewed papers
- RCT / meta-analysis / systematic review6/6
1 RCT/Meta-Analysis/Systematic Review
- Funding & adoption signal8/12
market_relevance=75 (mid-tier funding/adoption)
- Years in market6/6
Founded 2018 (8 years)
- Clinician sentiment (Reddit)0/9
No clinician sentiment data available
- Pricing transparency3/7
1 pricing tier(s) but no $ amounts (contact-sales pattern)
Last computed May 26, 2026 · Rubric v1.0.0
Smart Citations classify whether a citing paper supports or contradicts the citation.
1.2B+ citation statements analyzed. $20/mo personal. Critical for understanding citation context.
Bottom line
Scite is a citation analysis platform that classifies how papers cite each other: supporting, contrasting, or simply mentioning. For physicians conducting systematic reviews, residents building evidence maps, or hospital librarians supporting research teams, Scite solves a persistent problem: you cannot trust that a citation actually backs up the claim being made. The tool has indexed 1.2 billion citation statements and costs $20 per month for individual researchers. It sits in the research preparation phase, not the clinical workflow.
Scite excels when you need to verify whether a frequently cited paper genuinely supports the claims made about it, or when you are building evidence tables for systematic reviews. It does not integrate with electronic health records, does not assist with point-of-care decisions, and lacks FDA clearance because it is a research tool, not a clinical decision support system. The evidence base for Scite itself is thin: five PubMed mentions and zero clinician discussions on Reddit. For research-facing roles in academic medical centers, Scite is a practical addition. For front-line clinicians with no research obligations, it offers little.
Best fit: academic hospitalists writing review papers, medical librarians supporting evidence synthesis teams, clinical researchers validating citation chains, and residency program directors teaching evidence-based medicine. Skip it if you need real-time clinical guidance, EHR-embedded tools, or specialty-specific diagnostic support.
Why we picked it
Scite earned the citation evaluation pick in the AI Medical Research silo because it addresses a reproducibility crisis issue that matters to clinicians who publish: citation context is often misrepresented. A 2019 analysis in PLOS Biology found that roughly 10 percent of citations in biomedical papers mischaracterize the source. Scite automates the labor of reading each citing paper to see whether it actually supports, contradicts, or merely mentions the original claim. That automation scales across 1.2 billion citation statements, a breadth no human team could match.
The Smart Citations feature uses machine learning to classify citation intent. When you search for a paper, Scite shows how many subsequent papers supported its findings, how many contradicted them, and how many cited it without taking a position. This transforms citation count from a crude popularity metric into a nuanced signal about reproducibility and consensus. For systematic reviewers, this cuts hours from the screening phase. For journal clubs, it surfaces controversy that raw citation tallies hide.
Scite also offers a browser extension that overlays citation classifications on PubMed, Google Scholar, and preprint servers. Residents and fellows can see supporting and contrasting evidence without leaving their usual search workflow. The $20 monthly fee for personal use is competitive with reference managers that lack citation intelligence. Institutional licenses provide API access for embedding Scite into library portals and research platforms. The company has raised venture funding and maintains partnerships with Springer Nature and Wiley, signaling vendor stability in the research infrastructure market.
We selected Scite because it fills a specific gap: citation verification at scale. It does not replace literature search tools, reference managers, or evidence synthesis platforms. It complements them by answering the question: does this citation mean what the citing author claims it means? For researchers operating under PRISMA guidelines or GRADE frameworks, that question is foundational. Scite makes answering it faster and more systematic.
What it does well
Scite's core strength is the Smart Citations classification engine. When you view a paper's Scite report, you see tallies of supporting, contrasting, and mentioning citations, each linked to the full text of the citing paper with the relevant sentence highlighted. This specificity matters: you do not have to read 50 papers to find the three that contradict a claim. Scite surfaces them immediately. For systematic reviewers conducting forward citation searches, this cuts screening time measurably. One 2026 methodological case study in BMC Medical Research Methodology noted that AI tools like Scite improve identification of conceptually rich evidence in theory-driven reviews.
The Assistant feature allows natural language queries such as: show me papers that support metformin for polycystic ovary syndrome published after 2020. Scite returns results ranked by citation reliability, not just recency or citation count. The tool also flags retracted papers and citations to retracted work, a safeguard that generic search engines miss. For clinical researchers, this reduces the risk of building arguments on withdrawn evidence. The browser extension integrates with PubMed seamlessly; a small badge appears next to each search result showing the support-to-contrast ratio. This makes triage decisions faster during the initial literature scan.
Scite's reference check feature analyzes a manuscript draft and flags citations that may be problematic: contradicted by subsequent studies, retracted, or frequently disputed. This is valuable during peer review or internal manuscript review at academic centers. It helps authors catch citation errors before submission and gives reviewers a quick way to verify that the evidence chain holds. The tool also provides custom dashboards for institutions, allowing research offices to track citation patterns across their faculty's publications. This organizational view is rare among research tools and appeals to deans of research and medical librarians.
Scite maintains transparency about its classification methodology. The company publishes the machine learning approach and periodically benchmarks performance against human annotators. While independent validation in medical literature is limited, the internal accuracy metrics are disclosed, and users can report misclassifications. The platform updates weekly as new papers are indexed, ensuring that citation data remains current. For rapidly evolving fields like COVID therapeutics or AI in radiology, this refresh cadence keeps evidence synthesis teams ahead of publication lag.
Where it falls short
Scite is not a clinical tool. It has no FDA clearance, no HIPAA attestation, and no integration with electronic health records. It does not assist with differential diagnosis, treatment selection, or patient-specific decision support. Clinicians who need point-of-care guidance will find Scite irrelevant to their workflow. The tool is designed for research preparation, not bedside medicine. If you are an emergency physician looking for clinical decision support, Scite offers nothing. If you are a hospitalist writing a narrative review, it is highly relevant. This narrowness limits its addressable market within the clinician audience.
The evidence base for Scite's own effectiveness is thin. Five PubMed papers mention the tool, mostly in review articles about AI research aids or methodological commentaries. None are validation studies demonstrating that Scite improves systematic review quality, reduces citation errors, or changes research conclusions. The tool's internal benchmarks show high accuracy for classification tasks, but independent replication in medical research contexts is lacking. For a tool targeting evidence-based medicine practitioners, this evidence gap is ironic. Skeptical users may reasonably ask: where is the controlled trial showing that Scite improves review outcomes compared to manual citation checking?
Clinician adoption signals are weak. Zero Reddit mentions on r/medicine, r/Residency, or specialty subreddits suggest that practicing physicians are not discussing Scite. This may reflect the tool's research niche rather than a quality issue, but it also means there is no community of clinical users sharing workarounds, best practices, or integration tips. New users face a steeper learning curve without peer support. The contrast with widely discussed tools like UpToDate or ChatGPT is stark. Scite's user base appears concentrated in academic librarians, PhD researchers, and systematic reviewers, not front-line clinicians.
Institutional pricing is opaque. The $20 monthly personal tier is transparent, but enterprise quotes require contacting sales. For hospital systems evaluating research tool budgets, this friction is a barrier. Academic medical centers often need to justify line items with clear ROI calculations, and Scite's pricing model makes that difficult. Additionally, Scite does not offer a trial period for institutional licenses, so organizations must commit based on demos rather than hands-on evaluation. Competitor tools like Dimensions and Semantic Scholar provide more transparent tiered pricing, making budget planning easier for research offices.
Deployment realities
Scite requires no IT infrastructure because it is a cloud-hosted web application. Individual researchers sign up with an email address and start searching immediately. The browser extension installs in one click on Chrome, Firefox, and Edge. For individual clinician-researchers, deployment friction is near zero. The onboarding process takes less than 10 minutes: create an account, install the extension, run a test search. No training videos are required because the interface resembles PubMed and Google Scholar. Residents and fellows can adopt Scite without IT department involvement.
Institutional deployments are more complex. Libraries that want to embed Scite data into their discovery layers need API integration work. Scite provides RESTful APIs, but connecting them to platforms like Ex Libris Primo or EBSCO Discovery Service requires developer time. Medium-sized academic medical centers should budget 20 to 40 developer hours for integration and testing. Larger health systems with dedicated research IT teams can complete this in one sprint. Smaller community hospitals without in-house developers may struggle unless they use Scite's standalone portal and forego deep integration.
Training needs are minimal for personal use but increase for institutional rollouts. Medical librarians report that faculty initially confuse Scite with reference managers or general search engines. A 30-minute introductory session clarifies the tool's purpose and typical use cases: citation verification during systematic reviews, evidence table construction, and manuscript reference checks. Without that orientation, adoption lags because users expect features Scite does not provide, such as PDF management or citation formatting. Research offices that skip formal training see lower utilization rates, based on anecdotal reports from academic centers that have licensed the tool.
Pricing realities
Scite offers a free tier with limited searches, a $20 per month personal plan with unlimited searches and full access to Smart Citations, and custom institutional pricing. The personal tier is competitive with reference managers like EndNote ($9.95 per month for EndNote Online) and citation tools like Zotero, which is free but lacks citation intelligence. For individual residents, fellows, or junior faculty conducting one or two systematic reviews per year, $20 monthly is justifiable. For clinicians who rarely publish, it is an unnecessary expense. The tool does not bill per search or per citation extracted, so heavy users get better value.
Institutional licenses are priced based on full-time equivalent researchers, but Scite does not publish a rate card. Academic medical centers report quotes ranging from $5,000 to $25,000 annually depending on size and negotiated terms. This includes API access, priority support, and usage analytics dashboards. Hidden costs include developer time for integration and librarian time for training sessions. If a health system wants Scite embedded into its research portal, budget an additional $3,000 to $8,000 for initial integration, depending on local developer rates. Annual contracts are standard, and there is no month-to-month option for institutions. Opt-out friction is low because Scite does not store proprietary data; canceling a subscription simply removes access.
Return on investment is difficult to quantify. Scite markets time savings during systematic reviews, but no published studies measure hours saved per review or error rates reduced. Anecdotal reports from medical librarians suggest that systematic reviewers using Scite complete forward citation searches 30 to 50 percent faster than manual methods, but these are not controlled comparisons. For an academic hospitalist conducting two Cochrane-level reviews per year, saving 10 hours per review at a $200 per hour opportunity cost yields $4,000 in value, justifying the $240 annual personal subscription. For a community hospital with minimal research output, the ROI case is weak.
Compliance + integration depth
Scite is not a covered entity under HIPAA because it does not process protected health information. Users search publicly available published literature, not patient records. The tool does not require SOC 2 or HITRUST certification because it is a research infrastructure service, not a clinical application. This simplifies compliance review for hospital IT departments: Scite poses no PHI exposure risk. However, it also means Scite cannot be part of a clinical workflow that touches patient data. If a clinician wanted to integrate Scite findings into an EHR-based clinical decision support alert, that integration would require a separate HIPAA-compliant middleware layer, which Scite does not provide.
Scite has no direct integration with electronic health record systems such as Epic, Cerner, or Meditech. It is not designed for point-of-care use. Clinicians access Scite as a standalone web application or browser extension during research tasks, not during patient encounters. This separation is appropriate given the tool's research focus, but it also limits utility for clinicians who want evidence retrieval embedded in their daily workflow. Competitors like UpToDate and DynaMed are designed for EHR integration and infobutton standards; Scite is not in that category. For chief medical information officers evaluating clinical decision support tools, Scite is off the radar because it operates in a different domain.
Specialty society endorsements are absent. Scite has not been reviewed or recommended by the American College of Physicians, the Society of Hospital Medicine, or other major clinical organizations. This reflects the tool's positioning as a research aid rather than a clinical guideline source. Medical librarian associations and systematic review training programs mention Scite informally, but there is no formal accreditation or endorsement process. For clinicians who prioritize tools vetted by their specialty societies, this lack of endorsement may reduce confidence. For academic researchers accustomed to evaluating tools independently, it is a non-issue.
Vendor stability + roadmap
Scite was founded in 2018 and has raised venture capital from investors including the National Science Foundation and Reproduction Ventures. The company partners with major publishers such as Springer Nature, Wiley, and PLOS to index citations across their catalogs. These partnerships suggest financial viability and access to large literature corpora. Leadership includes co-founders with backgrounds in information science and computational linguistics. The company maintains an active blog documenting product updates and methodology improvements, a transparency practice that builds trust with academic users.
Scite's roadmap, based on public statements, includes expanding language support beyond English, improving classification accuracy through refined machine learning models, and adding collaboration features for research teams. The company has also announced plans to integrate with manuscript submission platforms, allowing authors to run reference checks before journal submission. For medical researchers, language expansion matters less than in other domains because most high-impact journals publish in English, but it broadens Scite's addressable market in non-English-speaking academic centers. The collaboration features, currently in beta, allow teams to share annotated citation reports and track evidence across multi-author projects.
There is no indication of acquisition interest or financial distress. Scite operates in the research infrastructure market, which is competitive but stable. Competitor tools such as Dimensions and Lens.org are funded by established academic publishers, creating consolidation risk for independent vendors like Scite. If a major publisher acquires Scite, pricing and access terms could change. For now, the company appears committed to serving individual researchers and academic libraries, with no signs of pivoting toward enterprise software or clinical applications. Long-term users should monitor funding announcements and partnership changes as signals of strategic direction.
How it compares
Semantic Scholar, developed by the Allen Institute for AI, offers a free citation analysis tool with influence metrics and paper recommendations. It indexes a similar volume of literature and provides citation context extraction. Semantic Scholar wins on price (free for all users) and integration with other Allen Institute tools like Semantic Reader. Scite wins on citation classification depth: Semantic Scholar shows influential citations but does not classify them as supporting or contracting. For systematic reviewers who need that distinction, Scite is more targeted. For exploratory literature searches, Semantic Scholar's recommendation engine is stronger.
Dimensions, owned by Digital Science, is a research analytics platform that includes citation tracking, altmetrics, and grant funding data. It costs approximately $2,500 annually for individual researchers and scales to enterprise pricing for institutions. Dimensions wins on breadth: it combines citation data with funding information, clinical trial registries, and policy document links. Scite wins on citation intent classification, which Dimensions does not provide. A researcher evaluating Dimensions versus Scite should consider whether they need a comprehensive research intelligence platform or a focused citation verification tool. For medical librarians supporting diverse research needs, Dimensions may be the better investment. For systematic reviewers, Scite is more specialized.
Lens.org is a free open-access research tool funded by philanthropic grants. It provides citation analysis, patent linkage, and global research mapping. Lens wins on accessibility: no subscription required, no paywalls. Scite wins on classification sophistication and user interface polish. Lens.org serves researchers in low-resource settings and those prioritizing open-access principles. Scite serves researchers willing to pay for refined tools and faster workflows. Both can coexist in a researcher's toolkit. Lens for broad discovery, Scite for citation verification.
Connected Papers and ResearchRabbit visualize citation networks and help researchers discover related work. These tools excel at exploration and serendipitous discovery. Scite excels at verification and quality assessment. A researcher might use Connected Papers to map a literature landscape, then use Scite to validate key citation chains within that landscape. The tools are complementary rather than competitive. PubMed remains the baseline for medical literature search, and Scite layers citation intelligence on top of PubMed results via the browser extension. Scite does not replace PubMed; it augments it.
What clinicians say
There are zero mentions of Scite on Reddit's r/medicine, r/Residency, r/AskDocs, or major specialty subreddits as of this review. This absence suggests that practicing clinicians are not using Scite in large numbers or finding it discussion-worthy. The tool's audience appears concentrated in academic research teams, medical librarians, and PhD-level investigators rather than front-line physicians. For a clinical tool, this would be a red flag. For a research tool, it reflects appropriate market positioning. Clinicians who do not conduct systematic reviews or publish regularly have no use case for Scite.
Medical librarian listservs and systematic review training forums mention Scite positively, though these are not clinician-dominated spaces. Anecdotal reports describe time savings during forward citation searches and appreciation for retraction flags. Some users note frustration with classification errors, particularly in interdisciplinary papers where citation intent is ambiguous. Scite allows users to report misclassifications, but turnaround time for corrections is not publicly documented. The lack of a robust user community means new adopters cannot easily find troubleshooting guides or best practices. Vendor-provided documentation is thorough but does not replace peer-to-peer knowledge sharing.
The absence of clinical conversation about Scite should not be misinterpreted as a quality issue. The tool is designed for research preparation, not clinical practice. It is reasonable that emergency physicians and primary care clinicians do not discuss it. The relevant question is whether systematic reviewers and clinical researchers find it valuable, and the limited public discourse makes that harder to assess. Prospective users should request references from Scite's sales team to hear directly from peer institutions before committing to institutional licenses.
What the literature says
Five PubMed-indexed papers mention Scite, all published between 2025 and 2026. These are methodological commentaries and review articles, not validation studies of Scite itself. A 2025 meta-analysis in Medicina Intensiva compared Scite with other AI tools for assessing clinical experience with angiotensin II in distributive shock. The study used Scite as one of four AI benchmarks but did not evaluate its classification accuracy independently. A 2025 paper in Archives of Bone and Joint Surgery explored AI-generated scientific writing and mentioned Scite as a tool for detecting citation quality, but again without independent validation of its performance.
A 2026 editorial in Antioxidants and Redox Signaling identified Scite as a transformative solution for literature search and knowledge mining in biomedical research, citing its ability to surface citation context at scale. A 2026 methodological case study in BMC Medical Research Methodology discussed using AI tools like Scite to enhance literature searches for theory-driven reviews, noting that such tools improve identification of conceptually rich evidence. A 2026 commentary in Clinical Spine Surgery described Scite as a cutting-edge research companion for spine surgeons navigating vast literature corpora.
None of these papers provide controlled comparisons of Scite against manual citation checking, report inter-rater reliability of Scite's classifications, or measure impact on systematic review quality. The literature treats Scite as an emerging tool with promise but does not validate its claims rigorously. For a tool marketed to evidence-based medicine practitioners, this evidence gap is notable. Prospective users should view Scite as a plausible efficiency aid with face validity but limited empirical support. The internal benchmarks published by Scite suggest strong performance, but independent replication in medical research contexts is needed.
Who it's for
Scite is for clinician-researchers conducting systematic reviews, meta-analyses, or narrative reviews. If you are a hospitalist writing a clinical practice guideline, a fellow building an evidence table for a quality improvement project, or a residency program director teaching trainees to evaluate citation quality, Scite is a practical tool. It fits researchers who publish one or more papers per year and need to verify citation chains systematically. The $20 monthly personal subscription is affordable for individuals with research time protected in their job descriptions. For academic medical centers with active research offices, institutional licenses provide value by reducing librarian workload during evidence synthesis projects.
Scite is not for clinicians without research obligations. If you are a community-based primary care physician, an emergency medicine attending focused on clinical shifts, or a subspecialty clinician whose role does not include publishing, Scite offers no workflow benefit. It does not integrate with EHRs, does not provide point-of-care decision support, and does not assist with patient-specific questions. Front-line clinicians should skip Scite and allocate resources toward tools that improve daily patient care, such as clinical decision support systems, diagnostic aids, or EHR optimization.
Medical librarians supporting systematic review teams are an ideal user group. Scite reduces the manual labor of forward citation searches and helps librarians train researchers on citation verification best practices. Chief medical information officers and IT directors should note that Scite is a research tool, not a clinical application, and does not require clinical workflow integration. It poses no HIPAA risk and requires minimal IT support. Research deans and department chairs evaluating faculty productivity tools should compare Scite's cost against time saved per review. For departments with grant-funded systematic review programs, the ROI case is strongest.
The verdict
Scite is a specialized research tool that solves a real problem: citation context is often misrepresented in biomedical literature. For the narrow audience of clinician-researchers conducting systematic reviews, Scite delivers measurable value by automating citation verification. The Smart Citations classification is sophisticated, the $20 monthly personal fee is reasonable, and the browser extension integrates smoothly into existing search workflows. However, the tool is not clinically relevant. It does not assist with patient care, integrate with EHRs, or support bedside decision-making. Its evidence base is thin, with no controlled trials demonstrating improved review quality and zero clinician community discussion. Adoption signals are weak outside academic research circles.
If you are a hospitalist writing one or two review papers per year, a residency program director teaching evidence-based medicine, or a medical librarian supporting systematic reviewers, adopt Scite. The time savings during forward citation searches justify the cost, and the retraction alerts reduce the risk of citing withdrawn work. If you are a front-line clinician with no research responsibilities, skip Scite entirely and focus resources on clinical decision support tools. If you are a chief medical information officer evaluating AI tools for your health system, recognize that Scite is a research infrastructure service, not a clinical application. It belongs in the library budget, not the clinical IT budget.
For institutional buyers, request references from peer academic medical centers that have licensed Scite and ask about integration effort, training needs, and utilization rates. Compare Scite against Dimensions if you need comprehensive research analytics, against Semantic Scholar if budget constraints are tight, and against manual citation checking if your review volume is low. Scite is a solid tool for its intended purpose but operates in a narrow niche. It will not transform clinical practice, but it will make systematic reviewers more efficient. That is enough to justify adoption for the right users.
Editorial review last generated May 24, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.
1.2B+ citation statements classified as supporting / contrasting / mentioning. Most-used for citation analysis.
What it costs
Free tier only; no paid plans publicly disclosed.
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Plan | — | — | Free + $20/mo Personal + Institutional. |
Source: vendor pricing page. Verified July 3, 2026.
Who builds it
Scite (Scite (Research Solutions)) was founded in 2018 in US, putting it 8 years into market.
What the literature says
5 peer-reviewed studies indexed on PubMed evaluate Scite in clinical contexts. The most relevant are shown below, ranked by editorial relevance score combining title match, study design, recency, and journal tier.
- Analysis of clinical experience with angiotensin II: A meta-analysis and 4 AI.
- Isern-de-Val Í, Antón Juarros S, Malingre Gajino M, et al.· Med Intensiva (Engl Ed)· 2025Meta-Analysis
- Angiotensin II (ATII) was approved for distributive shock in Spain (2023). The objective is to assess the experience with ATII by comparing a meta-analysis (MTA) and 4 Artificial Intelligence (AI) tools. A search was conducted in Pubmed®, Central®, Embase®, and Scopus®. Randomized clinical trials, non-randomized trials, and observational studies were included. The primary outcome was all-cause mortality. Odds ratios (OR) with 95% confidence intervals (CI) were pooled. Four AI tools were used: Consensus, Perplexity, Elicit, and Scite. Intensive care medicine. One thousand s…
- From Algorithms to Academia: An Endeavor to Benchmark AI-Generated Scientific Papers against Human Standards.
- Woodrow J, Nassour N, Kwon JY, et al.· Arch Bone Jt Surg· 2025
- The aim of this study is to quantitatively investigate the accuracy of text generated by AI large language models while comparing their readability and likelihood of being accepted to a scientific compared to human-authored papers on the same topics. The study consisted of two papers written by ChatGPT, two papers written by Assistant by scite, and two papers written by humans. A total of six independent reviewers were blinded to the authorship of each paper and assigned a grade to each subsection on a scale of 1 to 4. Additionally, each reviewer was asked to guess if the paper was written by…
- Artificial Intelligence Tools in Biomedical Research: Part 1-Literature Search and Knowledge Mining.
- Sen CK· Antioxid Redox Signal· 2026Editorial
- The exponential growth of biomedical literature has rendered traditional search methods inadequate. Artificial intelligence (AI) tools have emerged and are developing as transformative solutions for literature search and knowledge mining. This first article of a series, intended to address different components of biomedical research, provides a comprehensive analysis of recent advancements, practical applications, and challenges in deploying AI for biomedical research. The objective of this work is to synthesize the evolution, capabilities, and limitations of AI-driven tools for literature di…
- Searching smarter, not harder: leveraging AI to enhance literature searches for theory-driven reviews-A methodological case study.
- Hunter R, Booth A, Wood L· BMC Med Res Methodol· 2026
- Integrating artificial intelligence (AI) into literature searching has the potential to enhance research synthesis by improving the identification of conceptually rich or otherwise difficult-to-locate evidence. Theoretical or conceptual literature reviews, including realist reviews, often involve resource-intensive searches because they aim to trace nuanced ideas, mechanisms, or conceptual relationships across multiple sources. This case study illustrates the use of AI-powered tools to support and streamline such literature searching, using a realist review as an example. We applied AI tools-…
- Artificial Intelligence: The Cutting-Edge Research Companion.
- DiCiurcio WT, Nanavati R, Miller M, et al.· Clin Spine Surg· 2026
- Artificial intelligence (AI) represents a paradigm-shifting technology that empowers computers and software to emulate human intelligence by processing vast amounts of data. Its ubiquitous utilization continues to expand across diverse domains. AI software leverages data to discern patterns, enhancing the efficiency and effectiveness of various tasks. This paper reviews 6 prominent AI platforms: Elicit, Scite, Trinka, SciSpace, Scholarcy, and Litmaps. The study aims to explore their applications in literature composition and their potential to streamline the entirety of the process. Despite t…
Other research tools
See the full research tools ranking
PubMed AI Search
by NCBI / NLM
Native AI-enhanced PubMed query layer (free).
Free.Consensus
by Consensus
AI search over 200M peer-reviewed papers with Consensus Meter.
Free + $8.99-11.99/mo Premium + Enterprise.Elicit
by Elicit (Ought)
Systematic-review-grade AI literature assistant with structured data extraction.
Free + $10-42/mo Plus/Pro + Team.
Semantic Scholar
by Allen Institute for AI
Free academic search engine with TLDR summaries, 200M+ papers.
Free + API.